Page last updated: 2024-08-24

baicalin and Cardiac Toxicity

baicalin has been researched along with Cardiac Toxicity in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Eissa, LA; El-Ela, SRA; Zaghloul, RA1
Feng, P; Liu, N; Wang, S; Yang, Y1
Chu, L; Chu, X; Guan, S; Han, X; He, Q; Sun, X; Wang, X; Wu, Y; Wu, Z; Zhang, J; Zhang, M; Zhao, Y1

Other Studies

3 other study(ies) available for baicalin and Cardiac Toxicity

ArticleYear
Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways.
    Nutrition (Burbank, Los Angeles County, Calif.), 2022, Volume: 102

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; beta Catenin; Biomarkers; Cardiotoxicity; Doxorubicin; Flavonoids; Mice; Myocardium; NF-kappa B; Oxidative Stress; Toll-Like Receptor 4

2022
Baicalin regulates TLR4/IκBα/NFκB signaling pathway to alleviate inflammation in Doxorubicin related cardiotoxicity.
    Biochemical and biophysical research communications, 2022, 12-31, Volume: 637

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotoxicity; Doxorubicin; Inflammation; Myocytes, Cardiac; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Rats; Signal Transduction; Toll-Like Receptor 4

2022
Investigation of the ameliorative effects of baicalin against arsenic trioxide-induced cardiac toxicity in mice.
    International immunopharmacology, 2021, Volume: 99

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Cardiotoxicity; Disease Models, Animal; Flavonoids; Humans; Inflammation; Male; Mice; NF-kappa B; Oxidative Stress; Scutellaria; Signal Transduction; Toll-Like Receptor 4

2021